- Journalists Cover Cyclospora and Measles Outbreaks, and Changing Health Policies
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- Massachusetts behavioral health provider to close after 40+ years
- Why Baylor, Texas Children’s renewed their 73-year affiliation
- Dentsply Sirona posts $898M in Q2 revenue as Return-to-Growth plan progresses
- Justice Department files civil complaint against dental device manufacturer
- The moral injury angle ASC operators haven’t fully reckoned with
- CVS Caremark taps chief growth officer
- Senators press Justice Department to act on Steward CEO contempt case
- Riley Children’s taps physician-in-chief
- The loopholes PE built to buy physicians are starting to crack
- AHMC Healthcare names corporate COO
- 6 competencies, 200 leaders: How a Colorado hospital is rethinking advancement
- As the IPO list disappears, who decides what goes to an ASC?
- Prime Healthcare’s outlook boosted by Fitch
- Medtronic ordered to pay $88M in hernia mesh case
- Saint Francis taps Oklahoma hospital president
- Pediatric dentistry chain seeks state approval $3.8M ASC acquisition
- Pediatric dentistry chain seeks state approval $3.8M ASC acquisition
- 24 state behavioral health policy updates
- Adventist Health, Rady Children’s launch NICU partnership
- 5 highest-paid gastroenterologists in Chicago
- Considering the ASC model? 3 physicians weigh in
- The cardiologist paycheck in 2026: 10 numbers to know
- North Dakota executive order bans kratom
- 5 DSOs making headlines
- Heartland Dental adds 6 offices
- Imagen Dental Partners adds Texas practice
- 5 acquisitions shaking up gastroenterology in 30 days
- Community Behavioral Health Clinics served 3.4 million people in 2025, up 13%
- HCA’s urgent care acquisition spree
- Where GI is booming and where it’s about to run out of physicians
- 60+ House Democrats press VA on mental healthcare staffing gaps
- FDA Reverses Course, Approves First mRNA Flu Shot
- DC opioid settlement funds to cover Medicaid costs
- Massachusetts becomes first state to enforce dental loss ratio standards
- Rebids, resignations and reshuffling: California psych nurse ratios reshape workforce
- Industry Voices—AI won’t fix nurse burnout. Nurses will
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Insurers see positive results in managing health costs in Q2
- Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape
- UPMC, KLAS Research study examines AI adoption trends, governance barriers
- The AI boom could boost Epic's position, execs say. Here's where AI startups can still win
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Novo Nordisk makes Omnicom agency of record for US media buying
- Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Budget Battle Erupts in Nation’s Capital Over Opioid Settlement Money
- Watch: Why Abortions Are on the Rise Since ‘Roe’ Was Overturned
- AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league
- 1 in 5 physicians experience depression: Survey
- States battle dental workforce shortages: 4 updates
- VerilyMe, Bausch + Lomb visualize dry eye education in new collaboration
- Arkansas oral surgery practice hit with data breach
- Dentist takes ownership of Pennsylvania dental practice
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle
- UM Health-Sparrow breaks ground on $83M behavioral health facility
- 9 behavioral health layoffs to know | 2026
- Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy
- New bipartisan 340B reform bill curbs HHS' rebate pilot
- Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat
- CCBHC model continues to expand, but faces some funding constraints
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- Senate committee advances Fauci contempt referral; Schwartz confirmed as new CDC director
- Millie joins UCSF Health's clinically integrated network to coordinate maternity care
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Oscar Health hikes 2026 outlook after record profitability during first half of the year
- Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
- Sarepta’s new CEO Michael Severino faces critical milestones to prove growth
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Listen to the Latest ‘KFF Health News Minute’
- Watch: Democratic Senator Proposes a Fix for American Healthcare — Covering All Kids
- Medicaid Work Rule Leaves Homeless People in the Cold
- Sanofi asked to change Dupixent ads after Galderma challenge
- Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio
- On the heels of star rating win, Clover Health boosts outlook on strength of MA membership growth in Q2
- Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
- ViiV rolls out long-acting HIV campaign targeting ‘future you’
- Fitch: 2025 likely 'a brief operational peak' for nonprofit hospitals ahead of OBBBA changes
- HHS announces decertification of Kentucky-based organ procurement organization Network for Hope
- Autism Therapy Spending Quintuples, Prompting Federal Push For State Oversight
- AstraZeneca, CSPC to form joint venture for biologics manufacturing
- Alcon survey spots gaps in teen eye care ahead of back-to-school season
- Ardent Health offsets Q2 volume stumble by tightening costs, renegotiating contracts
- Could The Air You Breathe Be Triggering Painful Arthritis Flares?
- Childhood Obesity Might Impact Women's Future Ability To Give Birth
- Amwell deepens partnership with Defense Health Agency, boosts 2026 revenue outlook
- AI-Managed Oxygen Promotes More Stable Oxygen Levels In Patients
- Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability
- Novo CEO has 'no doubt' on eventual share price recovery as Wegovy pill continues to wow
- Lilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom
- Maja Pedersen named president, taking reins of Fujifilm's CDMO as CEO role is retired
- ‘No discussions’ ongoing for AstraZeneca-Bristol Myers merger: Reuters
- Type 2 Diabetes Might Make Menopause Worse
- ‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
- AI Is Being Used To Boost Medicaid Enrollment, But Not Without Concerns
- Pesticides Linked To Increased ALS Risk, Review Finds
- Pediatricians and Health Departments Sidestep Trump’s CDC on Vaccine Guidance
- Baltimore Is Rethinking What It Means To Call 911 — And Who Responds
- Closing the gaps in MS care during pregnancy
- CVS enhances supports for patients taking GLP-1s
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Hinge Health to acquire Cylinder Health in a $105M deal to expand into gastrointestinal care
- Women’s ‘new health ecosystem’ takes shape on Reddit: report
- Women’s ‘new health ecosystem’ takes shape on Reddit: report
- Michigan Reports First U.S. Deaths From Parasite Outbreak
- Breathing Exercises Can Curb Addiction Cravings, Review Finds
- Fierce Healthcare Data Breach Tracker: Record-breaking data breach at Unlimited Technology Systems
- Collagen Peptides Show Promise For Women's Bone Health
- As AI use rises, younger adults skip preventive care, survey finds
- Bacterial Vaginosis Tied To Tripled STI Risk, Major Study Finds
- High Body Fat, Not BMI, Linked To Lower Sperm Counts
- New Smart Ring Can Track Blood Sugar, Alcohol
- People With Disabilities Fear Service Cuts As Trump's DOJ Questions Legal Protections
- AI Is Being Used to Boost Medicaid Enrollment, but Not Without Concerns
- Nurses Chase Cyclospora, Aided by Interviews, Fast-Food Receipts — And the Messy Details
- Healthcare Dealmakers—Erlanger joining Prisma, TruBridge acquired and more
- VA Launches Nationwide Trial Of GLP-1 Drug Semaglutide For Problem Drinking
- Premature Menopause Linked To High Blood Pressure
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Transgender 'Top Surgery' Patients Aren't Receiving Adequate Breast Cancer Advice, Researchers Say
- Does Childhood Divorce Increase Kids' Risk Of Adult Depression — Or Is It Other Parental Problems?
- Once-Weekly Pill Could Revolutionize HIV Treatment
- Uninsured But Undaunted, A Surgical Patient Searched The Globe For A Deal
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- Daily Routine Key To Good Health, Study Says
- Rising Stars: Publicis CoLab’s Brielle Hoffman is a part of the ‘decision-making that truly affects people’
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Insurers propose a median ACA rate hike of 15% for 2027: KFF
Michigan healthcare freedom community forum
Generic left wing, health care, and pharmaceutical groups are coalescing into a political bloc which vows to derail the nomination of Robert F. Kennedy Jr. as the next Health & Human Services Secretary:
Kennedy opposed by advocates for US health post
By Michael Erman and Julie Steenhuysen - December 16, 2024Summary
* Coalition of 40+ groups opposes Kennedy's HHS nomination
* Groups are concerned about Kennedy's potential vaccine policies
* Advocates target Republican senators to block confirmationDec 16 (Reuters) - An expanding coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top U.S. health job over concerns about his activism against vaccines and other health issues, according to the groups' representatives.
Obamacare advocate Protect Our Care, influential consumer group Public Citizen and Community Catalyst, which fights for equality in healthcare, are part of a coalition of at least 40 organizations targeting a group of Republican U.S. senators to help block Kennedy's confirmation as U.S. Secretary of Health and Human Services.
The Committee to Protect Health Care, a grassroots physician organization, has also amassed nearly 16,000 signatures from physicians who oppose Kennedy's nomination.
The efforts come as Kennedy heads to Capitol Hill to win support following his nomination by President-elect Donald Trump including by meeting with incoming Senate health committee chairman Republican Bill Cassidy, a Cassidy staff member confirmed.
"We’re going to work to block his nomination. And I think we will succeed," said Peter Maybarduk, access to medicines director of Public Citizen, a consumer group founded by Ralph Nader in 1971, which has worked for causes including drug safety and airbags in cars. "Even if RFK Jr. can't amass the power to take down vaccine funding, elevating his falsehoods to some kind of officialdom is a danger all its own."
Kennedy has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades. He disputes the anti-vaccine label and has said he would not prevent Americans from getting inoculations, but is a founder of the anti-vaccine group Children's Health Defense and in a 2023 interview with Lex Fridman said no vaccines are safe and effective.
Kennedy has said he wants to work to end chronic disease, break any ties between employees at the U.S. drugs regulator and industry, and advise U.S. water systems to remove fluoride. Trump has said he will discuss the U.S. childhood vaccination program with Kennedy, and on Monday said all vaccines should be looked at.
Kennedy's spokesperson did not respond to a request for comment. His advocates have said opposition to his nomination stems from corporate interests.
Protect Our Care Executive Director Brad Woodhouse said the group has hired lobbying and advocacy teams in more than six states to try to win over the Republican senators seen as possible "no" votes given their track records on health issues or because they are likely to face strong 2026 reelection challenges.
The groups are also raising money to buy ads and conduct polling on health issues, they said.
Protect Our Care, which works to defend the Affordable Care Act, said it will likely hold media briefings with public health experts and politicians to call attention to Kennedy's policies as he meets with senators.
Others have opposed the nomination as well. Pfizer board member Scott Gottlieb, a former FDA commissioner under Trump, told CNBC last month Kennedy's agenda "will cost lives in this country." The Wall Street Journal's Editorial Board in a Dec. 4 column wrote that Kennedy could "disrupt access to life-saving medicines and the innovation ecosystem that creates them."
HHS has oversight for the FDA, the Centers for Disease Control and Prevention and the National Institutes of Health.
TARGETING SENATORS
Confirmation of Kennedy and other cabinet nominees requires a majority vote in the Senate. Kennedy needs the backing of 50 out of the 53 Republican senators if all 47 Democrats vote against him. The advocates are targeting senators in states including Alaska, Idaho, North Carolina, Iowa, West Virginia and Maine.
American Values 2024, a Super PAC that supports Kennedy, has initiated a video campaign defending the nominee.
In a video it posted on social media platform X, Jay Carson, who used to work for President Bill Clinton and other Democrats but now supports Kennedy, argues that opposition to Kennedy stems from a smear campaign by pharmaceutical companies.
"They're determined to keep him out of Washington, D.C.," the Super PAC said on X.
The top lobby group for drugmakers, Pharmaceutical Research and Manufacturers of America, declined to comment. In a Nov. 14 statement, the industry said it wants to work with the Trump administration.
Community Catalyst, which has raised millions since 1998 to support equal access to healthcare, said Kennedy's anti-vaccine rhetoric and position against fluoridated water pushed it to act.
Mona Shah, Community Catalyst's senior director of policy and strategy, said the group has worked for decades to improve dental care access in hard-to-reach communities that face racial discrimination where removing fluoride from drinking water could do the greatest harm.
"We really feel that some of these policies would hurt communities, really endanger children and families and truly make us sicker as a nation," Shah said.
The Committee to Protect Health Care's petition describes Kennedy's appointment as a threat to patient safety and "an affront" to public health. The group accepts no pharmaceutical industry funding.
Dr. Rob Davidson, the group's executive director and an emergency room physician in Michigan, said Americans need to be aware of Kennedy's "very dangerous" positions on topics like vaccines, and COVID-19 being engineered to target certain racial populations.
"We want to make sure people understand he's not just a kooky guy who says weird things," Davidson said.
More:
https://www.politico.com/live-updates/2024/12/16/congress/rfk-jr-opponents-buy-ads-00194493
RFK Jr. opponents buy ads in key senators’ states
By Daniel Payne - December 16, 2024Opponents of Robert F. Kennedy Jr.’s nomination to lead HHS are buying tens of thousands of dollars in ads across the states of key Republican senators as he plans to meet with them this week.
Protect Our Care, which has launched a Stop RFK War Room, has bought advertising slots — from digital ads to billboards — calling on constituents to urge their senators to oppose Kennedy’s nomination, leaders of the group told POLITICO.
“We’re going to accelerate our activity,” said Brad Woodhouse, executive director of Protect Our Care, a health advocacy group aligned with Democrats. “We think this week’s a big deal.”
The group is targeting GOP senators it believes could be persuaded to vote against Kennedy’s confirmation: Sens. Lisa Murkowski (R-Alaska), Mike Crapo (R-Idaho), Susan Collins (R-Maine), Bill Cassidy (R-La.), Thom Tillis (R-N.C.), Mike Rounds (R-S.D.), John Cornyn (R-Texas), Shelley Moore Capito (R-W.Va.) and the newly elected Jim Justice (R-W.Va.).
The ads connect Kennedy’s unsupported claims about the danger of vaccines to the deaths of more than 80 children during a measles outbreak in Samoa in 2019 — and argue that health professionals, scientists and the conservative Wall Street Journal editorial board oppose his confirmation, making it a safe position for Republicans.
Why it matters: Protect Our Care, along with several groups focused on public health, are arguing to senators — and the public — that Kennedy’s views on vaccines, medical authorities and key health policies would be detrimental to the U.S. population, should he lead HHS.
To block Kennedy, four Republican senators would have to oppose his confirmation if every Democrat votes no.
What’s next? Protect Our Care expects more campaigning against the nominee in the future.
“We will spend more,” Woodhouse said. “We’re just starting this process.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















